GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Oncologix Tech Inc (OTCPK:OCLG) » Definitions » Beta

OCLG (Oncologix Tech) Beta : 0.52 (As of Nov. 14, 2024)


View and export this data going back to 1987. Start your Free Trial

What is Oncologix Tech Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-11-14), Oncologix Tech's Beta is 0.52.


Oncologix Tech Beta Historical Data

The historical data trend for Oncologix Tech's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncologix Tech Beta Chart

Oncologix Tech Annual Data
Trend Aug04 Aug05 Aug06 Aug07 Aug08 Aug09 Aug10 Aug11 Aug12 Aug13
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.07 1.27 1.24 1.42 -1.05

Oncologix Tech Quarterly Data
Aug10 Nov10 Feb11 May11 Aug11 Nov11 Feb12 May12 Aug12 Nov12 Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.78 -1.91 -2.75 -4.79 -5.37

Competitive Comparison of Oncologix Tech's Beta

For the Shell Companies subindustry, Oncologix Tech's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oncologix Tech's Beta Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Oncologix Tech's Beta distribution charts can be found below:

* The bar in red indicates where Oncologix Tech's Beta falls into.



Oncologix Tech Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Oncologix Tech  (OTCPK:OCLG) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Oncologix Tech Beta Related Terms

Thank you for viewing the detailed overview of Oncologix Tech's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Oncologix Tech Business Description

Traded in Other Exchanges
N/A
Address
370 Amapola Avenue, Suite 200-A, Torrance, CA, USA, 90501
Oncologix Tech Inc is a Shell company. the company currently doesn't have any specific business and is looking forward to acquiring other companies.
Executives
Anthony Silverman director, officer: CEO and President 7625 E. VIA DEL REPOSA, SCOTTSDALE AZ 85258
Stanley Schloz other: Director, Resigned 12-27-07

Oncologix Tech Headlines

No Headlines